Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amyris Inc (AMRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 291,564
  • Shares Outstanding, K 76,526
  • Annual Sales, $ 143,450 K
  • Annual Income, $ -72,330 K
  • 60-Month Beta 0.39
  • Price/Sales 1.44
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.79
  • Growth Rate Est. (year over year) +55,910.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.72 unch
on 03/19/19
5.03 -26.04%
on 02/25/19
-0.81 (-17.88%)
since 02/19/19
3-Month
2.64 +40.91%
on 01/30/19
6.06 -38.61%
on 02/08/19
+0.14 (+3.91%)
since 12/19/18
52-Week
2.64 +40.91%
on 01/30/19
9.28 -59.94%
on 10/09/18
-3.02 (-44.81%)
since 03/19/18

Most Recent Stories

More News
Amyris Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Announces Signing of $300 Million Definitive Cannabinoid Agreement

EQNX::TICKER_START (NASDAQ:AMRS), EQNX::TICKER_END

AMRS : 3.61 (-5.25%)
Amyris Finalizes Cannabinoid Development, Licensing and Commercialization Agreement Containing $300 Million of R&D and Milestone Payments and a Long-Term Royalty Stream

Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it has signed...

AMRS : 3.61 (-5.25%)
Amyris to Present at 31st Annual Roth Conference on Tuesday, March 19, 2019

Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that management...

AMRS : 3.61 (-5.25%)
Analysts Estimate Amyris (AMRS) to Report a Decline in Earnings: What to Look Out for

Amyris (AMRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AMRS : 3.61 (-5.25%)
Amyris to Announce Fourth Quarter and Fiscal Year 2018 Financial Results on Monday, March 18, 2019

Amyris, Inc. (Nasdaq:AMRS) will report financial results for the fourth quarter and fiscal year ended December 31, 2018 after market close on Monday, March 18, 2019.

AMRS : 3.61 (-5.25%)
Amyris Is Selected by NIH Grant Recipient, IDRI, to Engineer Molecules for Vaccine Adjuvant Applications

Sustainable Squalene Replacement Needed for Pharma

AMRS : 3.61 (-5.25%)
Amyris Appoints Industry Veteran as President, Sweeteners and Ingredients, to Deliver Accelerated Growth

Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the appointment...

AMRS : 3.61 (-5.25%)
These 4 Marijuana Stocks Could Be Positioned For A Big Month

CORAL GABLES, FL / ACCESSWIRE / February 8, 2019 / The market, as many have come to recognize, has existed for a short period of time relative to other more established markets. Due to this fact, there...

AMRS : 3.61 (-5.25%)
BIO.CN : 0.690 (unch)
PYX : 31.91 (+4.14%)
Thinking about buying stock in Amyris Inc., Disney, Electronic Arts, Trevena Inc. or Take-Two Interactive?

InvestorsObserver issues critical PriceWatch Alerts for AMRS, DIS, EA, TRVN, and TTWO.

TRVN : 1.90 (+13.77%)
AMRS : 3.61 (-5.25%)
EA : 98.48 (-1.18%)
TTWO : 96.37 (+2.71%)
DIS : 113.21 (+0.08%)
What Is Amyris (AMRS), And Why Is Its Stock Soaring?

Shares of bioscience firm Amyris (AMRS) skyrocketed more than 70% on Tuesday after the company announced a collaboration deal focused on developing, licensing, and commercializing cannabinoid products....

AMRS : 3.61 (-5.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade AMRS with:

Business Summary

Amyris INC is an integrated renewable products company applying industrial synthetic biology to genetically modify microorganisms to serve as living factories. Amyris designs these microorganisms to produce defined molecules for use as renewable chemicals and transportation fuels. The Company is engaged...

See More

Key Turning Points

2nd Resistance Point 4.18
1st Resistance Point 3.99
Last Price 3.60
1st Support Level 3.71
2nd Support Level 3.62

See More

52-Week High 9.28
Fibonacci 61.8% 6.75
Fibonacci 50% 5.96
Fibonacci 38.2% 5.18
Last Price 3.60
52-Week Low 2.64

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar